Table 2

Functional and best corrected vision by patient group—pseudophakic compared with aphakic

WHO
category
Pseudophakic (n=84) Aphakic
(n=82)
All 166 Risk of poor outcome for aphakics VA <6/60
Odds ratio (95% CI)
Functional presenting vision
 ⩾6/18015  (17.9%)8  (9.8%)23  (13.9%)
 <6/18–6/60132 (38.1%)14 (17.1%)46 (27.7%)
 <6/60–3/60227 (32.1%)12 (14.0%)39 (23.5%)
 <3/60310 (11.9%)44 (53.7%)54 (32.5%)3.46  (1.72–7.02)
 PL403 (3.7%)3 (1.8%)
 NPL501 (1.2%)1 (0.6%)
Best corrected vision
 ⩾6/18050 (59.5%)28 (34.1%)78 (47.0%)
 <6/18–6/60125 (29.8%)31 (37.8%)56 (33.7%)
 <6/60–3/6021 (1.2%)17 (20.7%)18 (10.8%)
 <3/6038 (9.5%)3 (3.7%)11 (6.6%)3.25  (1.31–8.24)
 PL402 (2.4%)2 (1.2%)
 NPL501 (1.2%)1 (0.6%)
  • Relative risk for severe visual impairment (<6/60 = very poor outcome) in aphakics compared with pseudophakics.

  • Functional vision RR = 1.64 (95% CI = 1.25–2.16).

  • Best corrected vision: RR = 2.62 (95% CI = 1.29–5.3).